论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhao G, Yin X, Li Y, Shao J
Received 28 September 2016
Accepted for publication 23 February 2017
Published 19 April 2017 Volume 2017:10 Pages 933—939
DOI https://doi.org/10.2147/JPR.S123423
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Michael Schatman
Purpose: The study aimed to assess the combined effects of parecoxib with three
different doses of remifentanil and its effect on the stress and cough
responses following tracheal extubation under general anesthesia.
Methods: A total of 120 patients with American Society of
Anesthesiologists (ASA) scores of I or II, undergoing selective thyroidectomy
with total intravenous anesthesia (propofol-remifentanil) and tracheal
intubation, were randomly allocated to be treated with an intravenous injection
of parecoxib and a continuous infusion of remifentanil at 0.1 μg/kg/min (R1),
0.2 μg/kg/min (R2), 0.3 μg/kg/min (R3), or an isotonic saline injection
(the control group). Hemodynamic vital signs, emergence time, extubation time,
sedation-agitation scale (SAS) score, pain visual analog scale (VAS) score,
occurrence of coughing, and side effects were recorded before surgery and
during the peri-extubation period. The vital signs included blood pressure
(BP), heart rate (HR), respiratory rate (R), and peripheral arterial oxygen
saturation (SPO2).
Results: BP, HR, the occurrence rate of coughing, and
extubation awareness decreased with the dose of remifentanil, and the
differences among the groups were significant (P < 0.05). Emergence and extubation
time increased with the dose of remifentanil, and the differences among the
groups were significant (P < 0.05). The occurrence rates of
respiratory depression and bradycardia in group R3 were significantly higher
than those in other groups (P < 0.05). SAS and VAS were lowest in
group R3, and the differences among the groups were significant (P < 0.05). BP, HR, SAS, and VAS
increased with time in the remifentanil groups.
Conclusion: The combined use of parecoxib and a moderate dose of
remifentanil can effectively suppress the stress and coughing responses during
the peri-extubation period. The appropriate quantity of remifentanil was found
to be 0.2 μg/kg/min, as this dosage caused no side effects.
Keywords: remifentanil, continuous infusion,
stress response, coughing, tracheal extubation, anesthesia